HDAC7通过重新编程分支链氨基酸代谢来促进癌的进展
Hyeyoung Nam1, Anirban Kundu2, Suman Karki1
1Department of Urology, University of Alabama at Birmingham, Birmingham, AL, USA.
Science advances
|June 4, 2025
概括
基因组脱乙酶7 (HDAC7) 通过抑制分支链氨基酸 (BCAA) 代谢,驱动了侵略性的清细胞细胞癌 (ccRCC),导致患者的生存率低下.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症新陈代谢 癌症新陈代谢
背景情况:
- 清细胞细胞癌 (ccRCC) 是最常见的癌亚型.
- 代谢重编程是ccRCC的一个标志.
- 我们之前在ccRCC中发现了HDAC7的升高.
研究的目的:
- 研究HDAC7在ccRCC进展中的作用.
- 阐明HDAC7影响ccRCC攻击性的分子机制.
主要方法:
- 在ccRCC中对HDAC7表达的分析.
- 研究HDAC7对与BCAA代谢相关的基因表达的影响.
- 评估SNAIL1 (SNAI1) 表达和NOTCH信号激活的情况.
- 在体内评估瘤进展和侵略性表型.
主要成果:
- 在ccRCC中,HDAC7促进了侵略性表型和瘤进展.
- HDAC7抑制了参与分支链氨基酸 (BCAA) 代谢的基因.
- 减少的BCAA代谢与ccRCC患者的生存率下降相关.
- HDAC7诱导的BCAA代谢抑制通过NOTCH信号调节SNAIL1.
结论:
- HDAC7是ccRCC攻击性的关键驱动因素.
- 准HDAC7或BCAA代谢可能为ccRCC提供治疗策略.
- 通过HDAC7-介导的代谢重编程通过SNAIL1和NOTCH信号传递促进ccRCC的进展.
更多相关视频
06:24Oncogene Expression Analysis with Alterations in pH in a Pancreatic Ductal Cell Line
Published on: April 11, 2025
530
19:44Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen
Published on: May 30, 2012
18.8K
相关概念视频
Renal Regulation of Acid-Base Balance
733
Metabolic reactions in the body produce nonvolatile acids, such as sulfuric acid, which generate an acid load of approximately 1 mEq of H+ per kilogram of body weight daily. Excreting H+ in the urine is essential to balance this acid load.
In the kidneys, cells within the proximal convoluted tubules (PCT) and the collecting ducts secrete hydrogen ions (H+) into the tubular fluid. Specifically, in the PCT, Na+/H+ antiporters secrete H+ while reabsorbing Na+.
However, the intercalated cells in...
In the kidneys, cells within the proximal convoluted tubules (PCT) and the collecting ducts secrete hydrogen ions (H+) into the tubular fluid. Specifically, in the PCT, Na+/H+ antiporters secrete H+ while reabsorbing Na+.
However, the intercalated cells in...
733
mTOR Signaling and Cancer Progression
3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.9K
Tumor Progression
6.5K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.5K
Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
Adaptive Mechanisms in Cancer Cells
6.0K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.0K
Cancer Stem Cells and Tumor Maintenance
5.1K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.1K
